General Information of the Compound
| Compound ID |
CP0405985
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-[2-(3-chlorophenyl)phenyl]-N-piperidin-4-ylacetamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C19H21ClN2O
|
||||||||||||||||||
| Molecular Weight |
328.843
|
||||||||||||||||||
| Canonical SMILES |
Clc1cccc(c1)-c1ccccc1CC(=O)NC1CCNCC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C19H21ClN2O/c20-16-6-3-5-14(12-16)18-7-2-1-4-15(18)13-19(23)22-17-8-10-21-11-9-17/h1-7,12,17,21H,8-11,13H2,(H,22,23)
Show/Hide
|
||||||||||||||||||
| InChIKey |
HQIXQFFDDIVACN-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01310, Muscarinic acetylcholine receptor M1
Protein ID: PT01266, Muscarinic acetylcholine receptor M3